Understanding the Molecular Determinant of Reversible Human Monoamine Oxidase B Inhibitors Containing 2H-Chromen-2-One Core: Structure-Based and Ligand-Based Derived Three-Dimensional Quantitative ...

4. SSRIs and MAOIs Shutterstock Finding the right antidepressant can help alleviate your depressive symptoms, but more isn’t necessarily better. Batista says that combining selective serotonin ...

Rasagiline mesylate (N -propargyl- 1 [R]-aminoindan) is a second-generation, selective, irreversible inhibitor of monoamine oxidase type B (MAO-B) under investigation for the treatment of ...

Rasagiline: A Second-Generation Monoamine Oxidase Type-B Inhibitor for the Treatment of Parkinson's Disease Jack J. Chen; Anh-Vuong Ly Disclosures Am J Health Syst Pharm. 2006;63 (10):915-928.

Additionally, overexpression of monoamine oxidase B (MAO-B) induces oxidative stress and decreases cognitive function. In this study, we presented the novel dual inhibitors of ferroptosis and MAO-B ...

Psilocybin therapy improved cognitive performance, reduced mood dysfunction, motor, and nonmotor symptoms in patients with Parkinson disease.